Neeta Pandit-Taskar, MD
Nuclear Medicine · Pittsburgh, PANPI 1871570010
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $50,138 of the $59,559 with a category attached, or 84.2%. 8 manufacturers reported payments, led by Regeneron at 55.0% of the total. 2025 is the largest year on record at $45,590, more than ten times the $2,838 reported in 2019. Among nuclear medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $1167.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$33K
- Telix Pharmaceuticals$8K
- Blue Earth Diagnostics$8K
- Progenics Pharmaceuticals, Inc.$6K
- Astrazeneca UK Limited$5K
- AstraZeneca$976
- plus $60 from 2 others
Across 9 payments — averaging $31,772 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$282K
- Biontech SE$4K
What the payments were for
- Consulting fees$50,13884%
- Speaking & faculty fees$2,0003%
- Travel & lodging$5,3419%
- Food & beverage$2,0803%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 7 | $32,735 |
| Telix Pharmaceuticals | 17 | $7,807 |
| Blue Earth Diagnostics | 3 | $7,575 |
| Progenics Pharmaceuticals, Inc. | 12 | $5,574 |
| Astrazeneca UK Limited | 2 | $4,833 |
| AstraZeneca | 8 | $976 |
| GE HealthCare | 1 | $36 |
| Janssen Research & Development, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,559 in reported general payments places this provider in the 95th percentile of 25 nuclear medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Pittsburgh
- Tejvir BawaPittsburgh$0
- Daniel PrymaPhiladelphia$52K
- Abass AlaviPhiladelphia$16K
- David MankoffPhiladelphia$5K
- Hongming ZhuangPhiladelphia$452
- Mark TulchinskyHershey$385
- John HochholdPhiladelphia$360
- Alexandros PappasPhiladelphia$309
- Steven BrownPhiladelphia$127
- Ajay KumarPhiladelphia$115
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.